Objective: To investigate whether succeeding pregnancies will affect the maternal and neonatal docosahexaenoic acid (DHA, 22:6n-3) status. Design: Cross-sectional study. Subjects: Women who were pregnant for the 1st to 7th time and took part in a longitudinal study to investigate the essential fatty acid status of pregnant women and their infants. The total study population comprised 98 primigravidae (PG) and 146 multigravidae (MG). Main outcome measures: Fatty acid pro®les of phospholipids isolated from maternal plasma samples collected during pregnancy and after delivery, and of umbilical plasma, vein and artery, obtained immediately after birth. Results: The absolute (mg/L) and relative (% of total fatty acids) amounts of DHA in maternal plasma phospholipids (PL) were signi®cantly lower in MG than in PG. In addition, a signi®cant negative correlation was observed between gravida number and the DHA content in maternal plasma samples. The DHA de®ciency index (22:5n-6/22:4n-6) was signi®cantly higher and the DHA suf®ciency index (22:6n-3/22:5n-6) was signi®cantly lower in umbilical plasma of infants born of MG than in that of infants born of PG. The relative DHA content of umbilical artery and vein vessel walls was signi®cantly lower in MG-than in PG-neonates and signi®cant negative associations were observed between birth order and the relative amounts of DHA in cord tissues. Conclusions: These results indicate that the maternal DHA status becomes reduced after each following pregnancy, which may result in a lower neonatal DHA status. Whether or not this has also functional consequences needs to be investigated further. Sponsorship: Financial support for this project was provided by Nutricia Research.
Introduction
During the last trimester of pregnancy, the fetal requirements for docosahexaenoic acid (22:6n-3, DHA) are high due to rapid accumulation in neural (Clandinin et al, 1980) and retinal tissue (Clandinin et al, 1980; Martinez, 1992) . Fatty acid synthesis in human placenta and fetal tissue is probably rather low (see for review : Innis, 1991) and, therefore, most of the fetal DHA has to be derived from the mother by placental transfer. Fatty acid analysis of maternal blood samples, taken regularly throughout normal pregnancy, revealed that the DHA amounts (mg/L) in plasma phospholipids (PL) increase by approximately 50% during the course of pregnancy (Al et al, 1995a) . However, the ratio between 22:6n-3 and its`de®ciency' marker 22:5n-6 in maternal plasma PL decreased signi®-cantly during pregnancy. Neuringer and coworkers (Neuringer et al, 1986) showed that in prenatal and postnatal n-3 de®cient rhesus monkeys, the low 22:6n-3 content of retina and brain tissue was accompanied by a compensatory increase in 22:5n-6. Lower 22:6n-3 amounts in a combination with higher 22:5n-6 amounts have also been found in cerebral cortex of infants fed formula as compared to breast-fed infants (Farquharson et al, 1992; Makrides et al, 1994) . Therefore, the ratio between 22:6n-3 and 22:5n-6 may be considered as a DHA suf®ciency index. The decrease in this index in maternal plasma PL during the course of pregnancy suggests that the increase in the absolute amounts of DHA may be insuf®cient to prevent a reduction of the maternal DHA status during pregnancy. Six months after delivery, the DHA suf®ciency index had not yet returned to early pregnancy values, which suggests that the normalization of the maternal DHA status after pregnancy occurs rather slowly or may be incomplete. To investigate whether this relatively slow recovery affects the maternal DHA status during a following pregnancy, we determined the fatty acid pro®les of maternal plasma PL of a group of women who were pregnant for the ®rst time with that of women who experienced 1±6 pregnancies before. In addition, the fatty acid pro®le of umbilical plasma, and of umbilical vein and artery of their infants was assessed and related to birth order.
Methods

Subjects
The study population consisted of pregnant women who took part in a longitudinal study to investigate the essential fatty acid status of women and their infants during pregnancy (Al et al, 1995a; Al et al, 1995b) . To increase the number of women with higher gravida number ( ! 3), an additional thirteen women were recruited. The selection criteria for entering the study were singleton pregnancy, Caucasian race, diastolic blood pressure below 90 mm Hg, and the absence of any metabolic, cardiovascular, neurological or renal disorder. Excluded were women who developed pregnancy-induced hypertension or gestational diabetes, women who delivered their babies before 37 weeks of gestation or after 42 weeks of gestation, and women whose babies were not appropriate for gestational age (b Percentile 2.3 and`Percentile 97.7) based on the Dutch intra-uterine growth curves, making allowance for sex and parity (Kloosterman, 1970) . Ethical approval for this study was obtained from the Ethics Committee of the University hospital. All subjects gave their written informed consent.
The total study population comprised 244 women and their newborns of which 98 women were primigravidae (PG) and 146 were multigravidae (MG) with a mean (s.d.) gravida number of 2.94 (0.08). The distribution of the number of pregnancies among the 146 MG was as follows: 2nd pregnancy±56 women, 3rd±59 women, 4th±21 women, 5th±5 women, 6th±4 women and 7th±1 woman. Gestational age at delivery was 281 AE 0.76 d in PG and 281 AE 0.59 d in MG. The mean birthweight was signi®cantly (P 0.006) lower in PG (3314 AE 35.8 g) than in MG (3460 AE 37.7 g). The percentage boys (57.1% in PG, 55.5% in MG) and girls (42.9% in PG, 44.5% in MG) was not signi®cantly different between the two groups. Seventy-two women did undergo one or more abortions (spontaneous and/or induced before 16 weeks of gestation). This relatively high number can be explained by the fact that most of the women were recruited in the university hospital where the number of high-risk' pregnancies is higher than in a local hospital. The distribution of abortions among gravida number is given in Table 1 .
If the women with an abortion are excluded, 43 women were pregnant for the second time, 27 for the third time and 4 for the fourth time (mean AE s.d. gravida number 2.47 AE 0.07). Their mean gestational age was 280 AE 0.89 d and mean birthweight of their infants was 3469 AE 45.6, which was signi®cantly (P 0.008) higher than that in PG. In this group 41 (55.4%) boys and 33 (44.6%) girls were born.
Sample collection
Maternal venous blood samples were collected into EDTA tubes before the 16th week of pregnancy, around 22 weeks and 32 weeks of gestation, and within 24 h after delivery. Within 2 h after parturition, a blood sample from the umbilical vein and a piece of the umbilical cord were collected as well. Plasma was separated from the red blood cells by centrifugation and stored at 780 C, under nitrogen, until analysis. The umbilical cords were cut into three segments of about 5 cm each, rinsed with saline solution (sodium chloride, 0.9% w/v) and stored at 780 C until analysis.
Fatty acid analyses
The fatty acid compositions of phospholipids (PLs) isolated from maternal and umbilical plasma and umbilical artery and vein vessel walls were determined as described earlier (Al et al, 1995a; Foreman-van Drongelen et al, 1995) . At the start of the analysis, approximately 40 mg of 1,2-dinonadecanoyl phosphatidyl choline 2 ] was added to the plasma sample as an internal standard to quantify the absolute fatty acid amounts, and 20 mg of 10-heptadecenoic acid (C17:1) was added to check carry over of free fatty acids during the PL separation procedure. The results of the plasma samples were expressed in absolute (mg/L plasma) as well as relative amounts (% of total fatty acids). The results of the umbilical artery and vein vessel walls are presented in relative amounts only.
Data analyses
Data are presented as mean AE s.d., unless mentioned otherwise. Two indices were calculated to describe the docosahexaenoic acid status of the mother and that of her newborn: the docosahexaenoic acid de®ciency index (22:5n-6/22:4n-6, DHA de®ciency index) and the docosahexaenoic acid suf®ciency index (22:6n-3/22:5n-6, DHA suf®ciency index). The study was designed as a crosssectional study. For each sample moment the following statistical tests were performed: (i) differences between primigravidae and multigravidae in DHA content, DHA de®ciency index and DHA suf®ciency index values of maternal and umbilical plasma PLs, and of umbilical tissue PL were studied using the two-tailed Student's ttest; (ii) pearson correlation coef®cients were calculated to study the relationship between gravida number on the one hand and the DHA content, the DHA de®ciency index and DHA suf®ciency index values of maternal plasma PLs, umbilical plasma PLs, and umbilical tissue PLs on the other hand. Since the neonatal DHA status is positively associated with gestational age at birth (Al et al, 1995a) , multiple regression was performed on the umbilical fatty acid data to correct for differences in gestational age at birth. The Chi-square test was applied to compare categorical data, expressed as frequencies. In the group of multigravidae we distinguished between multigravidae who did undergo one or more abortions in previous pregnancies (incl. A) and multigravidae who did not (excl. A). The statistical analyses were done by use of the SPSS-PC program (SPSS Inc, 1988) .
Results
Maternal DHA status
In Table 2 the absolute (mg/L) and relative (% of total fatty acids) amounts of DHA in plasma phospholipids (PLs) are given. The absolute and relative DHA amounts in maternal plasma PL were signi®cantly lower in MG than in PG during gestation. Shortly after delivery, only the relative DHA plasma amounts were still signi®cantly lower in MG than in PG. If women who had undergone one or more abortions were excluded from the data analyses, the maternal plasma DHA amounts were still signi®cantly lower in MG than in PG (data not shown).
The mean maternal plasma values of the DHA de®-ciency index and DHA suf®ciency index are reported in Table 3 . The maternal DHA de®ciency index and DHA suf®ciency index values did not differ signi®cantly between PG and MG, with the exception of the maternal DHA suf®ciency index at 22 weeks of gestation, which was signi®cantly (P 2 0.05) lower in MG without previous abortions as compared with PG (data not shown). Neonatal DHA status In Table 4 , the absolute and relative amounts of DHA in umbilical plasma and tissue PL are shown. The absolute and relative DHA amounts in umbilical plasma were not signi®cantly different between PG and MG. In umbilical artery and vein, on the other hand, relative DHA amounts were signi®cantly lower in MG as compared to PG (see also Table 4 ). The DHA suf®ciency index values in umbilical plasma and in umbilical artery and vein were signi®cantly lower in MG than in PG (Table 3) , which also suggests a reduced DHA status in newborns of MG. This is also supported by the signi®cantly higher DHA de®ciency index values in umbilical plasma from MG (Table 3) .
Relationship of birth order with maternal and neonatal DHA status If the number of pregnancies was taken as a continuous variable (data from women with previous abortions included), signi®cant negative correlations were observed with maternal plasma DHA amounts, with umbilical artery and vein DHA amounts, and with umbilical plasma DHA suf®ciency index values (Table 5 ). All these associations were still signi®cant if data from women who had undergone one or more abortions were excluded. This exclusion resulted in additional signi®cant negative correlations between gravida number and the DHA suf®ciency index values in maternal plasma at 22 weeks of gestation, and the DHA suf®ciency index values in umbilical cord samples. A signi®cant positive correlation coef®cient was found between gravida number (abortions excluded) and DHA de®ciency index values in umbilical plasma PLs (Table 5) . If the DHA content in plasma PLs was expressed as mg/ L, signi®cant negative correlations were observed between gravida number and DHA concentration in maternal plasma PLs before 16 weeks of gestation (abortions included: r 70.14, P 2 0.03; abortions excluded: r 70.18, P 2 0.02), at 32 weeks (abortions included: r 70.18, P 2 0.007; abortions excluded: r 70.18, P 2 0.02) and after delivery (abortions included: r 70.14, P 2 0.04). Introducing gestational age in the multiple regression analyses did not alter the observed associations to a signi®cant extent. 
Discussion
The aim of this study was to investigate whether repeated pregnancies may have an effect on the maternal and neonatal docosahexaenoic acid (22:6n-3 DHA) status. To study this, we compared the maternal and neonatal DHA status of primigravidae (PG) with that of multigravidae (MG). The results of the present study demonstrated that the absolute and relative DHA amounts of maternal plasma PLs from multigravidae (MG) is signi®cantly lower than that of primigravidae (PG). A signi®cant negative correlation was observed between gravida number and the maternal plasma DHA amounts, suggesting that the maternal DHA becomes reduced after each subsequent pregnancy. The signi®cantly lower values of the docosahexaenoic acid suf®ciency index (22:6n-3/22:5n-6, DHA suf®ciency index) and signi®cantly higher values of the docosahexaenoic acid de®ciency index (22:5n-6/22:4n-6, DHA de®ciency index) in umbilical plasma of infants born of MG as compared to that of infants born of PG seem to indicate that the DHA status of secondary and successive children is lower than of ®rst born children. This is also supported by the signi®cantly lower DHA content in umbilical artery and vein vessel walls of MG than of PG. Furthermore, a signi®cant negative association was observed between birth order and the DHA amounts in umbilical cord tissue. Strikingly, of the in total 39 fatty acids analysed, DHA was the only fatty acid for which a consistent association with gravida number was observed (data available on request). Carlson & Salem (1991) also reported a signi®cant negative effect of birth order on the neonatal DHA status, based on the DHA content of red blood cells from preterm infants. This also supports our hypothesis that if a woman has further children, she may start each next pregnancy with lower DHA stores, so that there is less DHA available for mobilization into the maternal blood and subsequent passing on to the fetus. Whether or not this has consequences for mother and child is yet unknown. It is possible that the newborn is able to compensate for the lower rate of placental transfer of preformed DHA. Recently, it has been shown that preterm infants at the age of one month are capable of synthesizing DHA from its precursor a-linolenic acid (Carnielli et al, 1996) . However, these data were mainly qualitative in nature, and the question remains whether the activity of the conversion is suf®cient to compensate for a reduced supply of preformed DHA. Further research is also needed to study fatty acid metabolism during intra-uterine period.
The study population of the present study is a group of healthy women and their infants. So far, no clinical adverse effects of the lower plasma DHA amounts in multigravidae have been observed. It could be, at least from a functional point of view, that there is dose-effect relationship: will the functional outcome only be affected if the DHA plasma levels are below a certain threshold value? It is also possible that there is a shift between the different lipid fractions in DHA content. It would be interesting, in future studies, to analyse also the other lipid fractions apart from phospholipids. However, in a study in which the fatty acid composition of plasma phospholipids, triglycerides and cholesterolesters from women with pregnancy-induced hypertension was compared with that from normal pregnant women, we did not ®nd any evidence for such a shift (Schouw et al, 1991) . Table 5 Pearson correlation coef®cients (r) between gravida number on the one hand and maternal and neonatal values of 22:6n-3 (% of total fatty acids), 22:5n-6/22:4n-6 and 22:6n-3/22:5n-6 on the other The data were analyzed with and without the women who had undergone one or more abortions, because this could have interfered with the results. One would expect that in the MG group with abortions, the mean gravida number of which is higher, the DHA status is lower than in the MG group without abortions. However, this was not the case: the results were more or less the same in both analyses. Since only pregnancies which were terminated before 16 weeks of gestation were de®ned as an abortion (spontaneous and/or induced), the reduction in maternal plasma DHA levels probably takes place after this period. This seems likely, because at that period and particularly during the third trimester of gestation, fetal DHA requirement is especially high (Clandinen et al, 1980; Martinez, 1992; Innis, 1991; Houwelingen et al, 1996) In a recently performed study among 176 healthy Dutch gravidae, no signi®cant differences in nutrient intake during the course of pregnancy were observed between PG and MG (Al et al, 1995b) , and therefore, the different DHA amounts in maternal plasma between PG and MG seems not to be due to a different fatty acid intake. Because the normal intake of DHA is rather low (estimated at 200 mg/ d) and the desaturation and elongation from its precursors occurs at a very slow rate only (Voss et al, 1992) , it seems that the increase in the absolute DHA amounts during pregnancy (Al et al, 1995a) are the result of an increased mobilization of DHA from maternal body stores, although a metabolic re-routing cannot be excluded. It remains to be investigated whether these stores are more used up by women who have been pregnant more than once than by women who are pregnant for the ®rst time.
Human milk contains small, but signi®cant amounts of DHA. This means that if a mother does breast feed her child, it will take probably a longer period to replenish her DHA stores. In a subsample (n 65) of the study population information on the type of infant's nutrition was available and it appeared that the percentage primiparae who did breast feed their child (40%) was not signi®cantly different from the percentage multiparae who breast feed (45%). The duration of breastfeeding did also not differ signi®cantly between primiparae and multiparae. Therefore, it seems that the method of feeding is not dependent on the number of older siblings, which has been reported by others as well (Gale & Martyn, 1996) , and this potential confounder is unlikely to have interfered with the results.
In a study of Crawford (Crawford et al, 1986) , it was demonstrated that the DHA content in milk samples from the stomach of rat pups was higher in the group born after a long birth interval than in the group born after a short birth interval. This suggests that the longer the time span between two pregnancies, the more time the mother has to replenish her fatty acid stores, and consequently, the better her capacity to provide DHA to the fetus. Unfortunately, we were unable to obtain data on birth intervals in the present study. In the Netherlands, the mean birth interval between the ®rst and second child is 2.8 y and 3.5 y for the following pregnancies (Central Bureau Statistics, 1996) . We observed that at least six months after parturition, the maternal DHA status, as calculated by the DHA suf®ciency index, was still signi®cantly lower as compared to the situation at the beginning of pregnancy (Al et al, 1995a) . The data of the present study seem to indicate that the maternal DHA status will stay reduced for a longer period.
Conclusions
The results of the present study showed that the absolute and relative amounts of DHA in maternal plasma PL are signi®cantly lower in women who have been pregnant more than once, than in women who were pregnant for the ®rst time. The lower maternal DHA status seems to result in a reduced DHA supply to the developing fetus. Whether or not this lowering effect of pregnancy on the maternal and neonatal DHA status has also functional consequences warrants further investigation.
